ScholarIQanswers from OpenAlex

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study

PaperCitations, authors & open-access status

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study have?

ScholarIQcitation count

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study has 40 citations in the OpenAlex counts ScholarIQ stores.

When was First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study published?

ScholarIQyear

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study has 2022 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study?

ScholarIQoa status

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study has gold oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study?

ScholarIQdoi

The DOI for First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study is on the source record.

Open the DOI →

What is the PMID of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study?

ScholarIQpmid

The PMID for First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study is on the source record.

Open the PMID →

What is the OpenAlex record for First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study?

ScholarIQopenalex

The OpenAlex for First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2 -altered NSCLC: a retrospective real-world POLISH study is on the source record.

Open the OpenAlex →

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study

How many citations does First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study have?

When was First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study published?

What is the open-access status of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study?

What is the DOI of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study?

What is the PMID of First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study?

What is the OpenAlex record for First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study?

Related on ScholarIQ